Odyssey Health (ODYY) Change in Account Payables (2014 - 2026)
Odyssey Health's (ODYY) quarterly Change in Account Payables came in at -$50174.0 in Q2 2026, down 801.6% year-on-year from $7151.4 in Q2 2025, and up 26.82% quarter-over-quarter from -$68563.0 in Q1 2026.
Odyssey Health (ODYY) Change in Account Payables (2014 - 2026) Analysis & Trends
Odyssey Health's Change in Account Payables history runs 13 years deep, the most recent figure standing at -$50174.0 for Q2 2026.
- On a quarterly basis, Change in Account Payables fell 801.6% year-over-year to -$50174.0 in Q2 2026; TTM through Apr 2026 was -$7046.0, a 104.16% decrease from a year earlier, with the FY2025 full-year figure at $228379.0, up 216.53% from the prior year.
- Change in Account Payables rose to -$50174.0 in Q2 2026 per ODYY's latest filing, from -$68563.0 in the prior quarter.
- Across five years, Change in Account Payables topped out at $824084.0 in Q4 2022 and bottomed at -$659632.0 in Q1 2023.
- The 5-year median for Change in Account Payables is $4115.0 (2025), against an average of $18850.2.
- Across the five-year window, Change in Account Payables jumped 473.04% in 2022 and slumped 801.6% in 2026, its largest moves.
- Year by year, Change in Account Payables stood at $824084.0 in 2022, then slumped by 93.47% to $53787.0 in 2023, then soared by 237.89% to $181743.0 in 2024, then tumbled by 59.68% to $73285.0 in 2025, then tumbled by 168.46% to -$50174.0 in 2026.
- Per Business Quant, the three latest ODYY Change in Account Payables figures stand at -$50174.0 (Q2 2026), -$68563.0 (Q1 2026), and $73285.0 (Q4 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.27 Bn | 175.98 Bn | 6.27 Bn | - |
| 2 | Stryker | 128.81 Bn | 125.93 Bn | 3.81 Bn | -198.00 Mn |
| 3 | Medtronic | 108.63 Bn | 99.41 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 68.42 Bn | 66.96 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 48.51 Bn | 44.84 Bn | 1.29 Bn | - |
| 6 | Dexcom | 28.39 Bn | 27.27 Bn | 750.30 Mn | - |
| 7 | GE HealthCare Technologies | 28.31 Bn | 26.03 Bn | 1.98 Bn | 221.00 Mn |
| 8 | Smith & Nephew | 26.93 Bn | 26.35 Bn | - | - |
| 9 | Koninklijke Philips | 25.47 Bn | 22.35 Bn | 2.07 Bn | - |
| 10 | Odyssey Health | 1.08 Mn | 782,508.17 | - | -50,174.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | -50,174.00 |
| Apr 30, 2026 | -50,174.00 |
| Jan 31, 2026 | -68,563.00 |
| Jan 31, 2026 | -68,563.00 |
| Oct 31, 2025 | 73,285.00 |
| Oct 31, 2025 | 73,285.00 |
| Jul 31, 2025 | 38,406.00 |
| Jul 31, 2025 | 38,406.00 |
| Apr 30, 2025 | -5,565.00 |
| Apr 30, 2025 | -5,565.00 |
| Jan 31, 2025 | 13,795.00 |
| Jan 31, 2025 | 13,795.00 |
| Oct 31, 2024 | 181,743.00 |
| Oct 31, 2024 | 181,743.00 |
| Jul 31, 2024 | -20,572.00 |
| Jul 31, 2024 | -20,572.00 |
| Apr 30, 2024 | 30,988.00 |
| Apr 30, 2024 | 30,988.00 |
| Jan 31, 2024 | -260,191.00 |
| Jan 31, 2024 | -260,191.00 |